Development and use of an indicator system for an addiction treatment center

2002 ◽  
Vol 15 (2) ◽  
pp. 49-58 ◽  
Author(s):  
U.W. Nabitz ◽  
J.A. Walburg
Keyword(s):  
Addiction Treatment ◽  
Indicator System ◽  
Treatment Center

scholarly journals Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine

2021 ◽  
Vol 11 ◽  
pp. 204512532098663
Author(s):  
David M. O’Shaughnessy ◽  
Ilana Berlowitz ◽  
Robin Rodd ◽  
Zoltán Sarnyai ◽  
Frances Quirk
Keyword(s):  
Repeated Measures ◽  
Addiction Treatment ◽  
Emotional Health ◽  
Neuropsychological Functioning ◽  
Well Being ◽  
Treatment Center ◽  
Therapeutic Effects ◽  
Spiritual Well Being ◽  
Treatment Safety ◽  
Addiction Treatment Program

Aims: The therapeutic use of psychedelics is regaining scientific momentum, but similarly psychoactive ethnobotanical substances have a long history of medical (and other) uses in indigenous contexts. Here we aimed to evaluate patient outcomes in a residential addiction treatment center that employs a novel combination of Western and traditional Amazonian methods. Methods: The study was observational, with repeated measures applied throughout treatment. All tests were administered in the center, which is located in Tarapoto, Peru. Data were collected between 2014 and 2015, and the study sample consisted of 36 male inpatients who were motivated to seek treatment and who entered into treatment voluntarily. Around 58% of the sample was from South America, 28% from Europe, and the remaining 14% from North America. We primarily employed repeated measures on a psychological test battery administered throughout treatment, measuring perceived stress, craving frequency, mental illness symptoms, spiritual well-being, and physical and emotional health. Addiction severity was measured on intake, and neuropsychological performance was assessed in a subsample from intake to at least 2 months into treatment. Results: Statistically significant and clinically positive changes were found across all repeated measures. These changes appeared early in the treatment and were maintained over time. Significant improvements were also found for neuropsychological functioning. Conclusion: These results provide evidence for treatment safety in a highly novel addiction treatment setting, while also suggesting positive therapeutic effects.

scholarly journals Implementation of Contingency Management at a Large VA Addiction Treatment Center

2017 ◽  
Vol 68 (12) ◽  
pp. 1207-1209 ◽  
Author(s):  
Hang Ruan ◽  
Cody L. Bullock ◽  
Greg M. Reger
Keyword(s):  
Addiction Treatment ◽  
Contingency Management ◽  
Treatment Center

scholarly journals Co -occurring Mental Disorders among In-patients in a Substance use Disorder Treatment Center in Plateau State, Nigeria

2020 ◽  
Vol 3 (1) ◽  
pp. 223-229
Author(s):  
D M Makput
Keyword(s):  
Substance Use ◽  
Drug Abuse ◽  
Mental Disorders ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Addiction Treatment ◽  
Treatment Center ◽  
Post Traumatic Stress ◽  
Functional Abnormality ◽  
Plateau State

Patients with psychoactive substance use disorders (SUD) often have co- occurring medical and mental disorders. This occurs as a result of a number of factors, for instance, drug abuse may facilitate the full expression of a latent psychiatric disorder; mental disorder may lead to SUD (drugs used for self- medication; or both SUD and mental disorders are caused by the same underlying brain deficit such as genetic vulnerability, neurotransmitter abnormality, structural or functional abnormality, and so on. After obtaining ethical clearance, the case notes of all patients who were admitted in the Centre for Addiction Treatment and Research, (CATR) Vom, Plateau state throughout the first quarter of year 2019 were traced. A systematic random sample of every third consecutive patient was selected beginning with the first patient admitted and relevant data were collected and analyzed. A total of fourty- eight (48) in-patients were analyzed. Ninety -four percent (94%) of the patients were males, the mean age of 23.6 + 5 years with 46% being below 25 years of age. Fourty-six percent (46%) had cannabis as their primary drug followed by alcohol (32%) and opioids (28%). Only 1 % had a history of injecting drug use. Twenty-nine percent (29%) of the SUD patients had co-occurring depression, nine percent (8%) had anxiety disorder, and five percent (4%) had Post Traumatic Stress Disorder (PTSD) in addition to their substance use disorder. In line with sustainable development goals (SDG) goal 3.5 which seeks to “strengthen prevention and treatment of substance abuse including narcotics drug abuse and harmful use of alcohol”; identifying co-occurring mental disorders among patients with substance use disorders is one way of moving closer towards achieving this SDG.

scholarly journals Spatial patterns of arrests, police assault and addiction treatment center locations in Tijuana, Mexico

Addiction ◽  
2016 ◽  
Vol 111 (7) ◽  
pp. 1246-1256 ◽  
Author(s):  
Dan Werb ◽  
Steffanie A Strathdee ◽  
Alicia Vera ◽  
Jaime Arredondo ◽  
Leo Beletsky ◽  
...  
Keyword(s):  
Spatial Patterns ◽  
Addiction Treatment ◽  
Treatment Center

scholarly journals Co -occurring Mental Disorders among In-patients in a Substance use Disorder Treatment Center in Plateau State, Nigeria

2020 ◽  
Vol 3 (1) ◽  
pp. 223-229
Author(s):  
D M Makput
Keyword(s):  
Substance Use ◽  
Drug Abuse ◽  
Mental Disorders ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Addiction Treatment ◽  
Treatment Center ◽  
Post Traumatic Stress ◽  
Functional Abnormality ◽  
Plateau State

Patients with psychoactive substance use disorders (SUD) often have co- occurring medical and mental disorders. This occurs as a result of a number of factors, for instance, drug abuse may facilitate the full expression of a latent psychiatric disorder; mental disorder may lead to SUD (drugs used for self- medication; or both SUD and mental disorders are caused by the same underlying brain deficit such as genetic vulnerability, neurotransmitter abnormality, structural or functional abnormality, and so on. After obtaining ethical clearance, the case notes of all patients who were admitted in the Centre for Addiction Treatment and Research, (CATR) Vom, Plateau state throughout the first quarter of year 2019 were traced. A systematic random sample of every third consecutive patient was selected beginning with the first patient admitted and relevant data were collected and analyzed. A total of fourty- eight (48) in-patients were analyzed. Ninety -four percent (94%) of the patients were males, the mean age of 23.6 + 5 years with 46% being below 25 years of age. Fourty-six percent (46%) had cannabis as their primary drug followed by alcohol (32%) and opioids (28%). Only 1 % had a history of injecting drug use. Twenty-nine percent (29%) of the SUD patients had co-occurring depression, nine percent (8%) had anxiety disorder, and five percent (4%) had Post Traumatic Stress Disorder (PTSD) in addition to their substance use disorder. In line with sustainable development goals (SDG) goal 3.5 which seeks to “strengthen prevention and treatment of substance abuse including narcotics drug abuse and harmful use of alcohol”; identifying co-occurring mental disorders among patients with substance use disorders is one way of moving closer towards achieving this SDG.

Telehealth Services for Substance Use Disorders: A 3-month Longitudinal Assessment of Intensive Outpatient Programming and Data Collection Practices During the COVID-19 Pandemic (Preprint)

2022 ◽  
Author(s):  
Kate Gliske ◽  
Justine Welsh ◽  
Jacqueline E. Braughton ◽  
Lance A. Waller ◽  
Quyen M. Ngo
Keyword(s):  
Substance Use ◽  
Data Collection ◽  
Addiction Treatment ◽  
Well Being ◽  
The United States ◽  
Treatment Center ◽  
Post Discharge ◽  
Health Crisis ◽  
Outcome Monitoring ◽  
Intensive Outpatient

BACKGROUND The onset of the COVID-19 pandemic necessitated the rapid transition of many types of substance use disorder (SUD) treatment to telehealth formats, despite limited information about what makes treatment effective in this novel format. OBJECTIVE To examine the feasibility and effectiveness of virtual intensive outpatient program (IOP) treatment for SUD in the context of a global pandemic, while considering the unique challenges posed to data collection during an unprecedented public health crisis. METHODS The study is based on a longitudinal study with a baseline sample of 3,642 patients who enrolled in intensive outpatient addiction treatment (in-person, hybrid, or virtual) from January 2020 to March 2021 at a large substance use treatment center in the United States. The analytical sample consisted of patients who completed the 3-month post-discharge outcome survey as part of routine outcome monitoring (n = 1,060) (response rate = 29%). RESULTS No significant differences were detected by delivery format in continuous abstinence (χ2 = 0.42, P = .81), overall quality of life (F(2,826) = 2.06, P = .13), financial well-being (F(2,767) = 2.30, P = .10), psychological well-being (F(2,918) = 0.72, P = .49), and confidence in one’s ability to stay sober (F(2,941) = 0.21, P = .81). Individuals in hybrid programming were more likely to report a higher level of general health than those in virtual IOP (F(2,917) = 4.19, P = .01). CONCLUSIONS Virtual outpatient care for the treatment of SUDs is a feasible alternative to in-person only programming leading to similar self-reported outcomes at 3-months post-discharge. Given the many obstacles presented throughout data collection during a pandemic, further research is needed to better understand under what conditions telehealth is an acceptable alternative to in-person care.

Sign in / Sign up

Export Citation Format

Share Document